Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2021 | 2020 | 2018 | 2012
Anzahl der Publikationen: 6

2021

Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavaillès, Vincent und Sixou, Sophie (2021): Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer. In: Journal of cancer research and clinical oncology, Bd. 147, Nr. 9: S. 2535-2544 [PDF, 1MB]

Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavailles, Vincent und Sixou, Sophie (2021): Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer. In: Journal of Cancer Research and Clinical Oncology, Bd. 147, Nr. 9: S. 2535-2544

2020

Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavaillès, Vincent und Sixou, Sophie (2020): Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers. In: Journal of Translational Medicine 18:94 [PDF, 1MB]

Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuweit, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavailles, Vincent und Sixou, Sophie (2020): Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor beta 1 Are Inversely Associated with Survival in Primary Breast Cancer. In: International Journal of Molecular Sciences, Bd. 21, Nr. 1, 330

2018

Semmlinger, Anna; Schönfeldt, Viktoria von; Wolf, Verena; Meuter, Alexandra; Kolben, Theresa Maria; Kolben, Thomas; Zeder-Goess, Christine; Weis, Florian; Gallwas, Julia; Würstlein, Rachel; Hermelink, Kerstin; Schmoeckel, Elisa; Harbeck, Nadia; Mayr, Doris; Mahner, Sven; Jeschke, Udo und Ditsch, Nina (2018): EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer. In: BMC Cancer 18:431 [PDF, 927kB]

2012

Arand, Julia; Spieler, David; Karius, Tommy; Branco, Miguel R.; Meilinger, Daniela; Meissner, Alexander; Jenuwein, Thomas; Xu, Guoliang; Leonhardt, Heinrich; Wolf, Verena und Walter, Joern (Juni 2012): In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases.
In: PLOS Genetics 8(6), e1002750 [PDF, 1MB]

Diese Liste wurde am Sat Nov 23 22:01:56 2024 CET erstellt.